![Matthew Onaitis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Onaitis
Financieel Directeur/CFO bij
MAINSTAY MEDICAL INTERNATIONAL
Profiel
Matthew W.
Onaitis is currently Director at Snp Bio, Inc. and Stratify Genomics, Inc. He serves as Chief Financial Officer at Mainstay Medical International Ltd. since 2018 and at Mainstay Medical Holdings Plc.
Formerly, Mr. Onaitis was Director-Legal Affairs at Elan Corp.
Plc from 2004 to 2005, Associate General Counsel at Biogen, Inc. in 2006, Secretary, Senior Vice President & General Counsel at Somaxon Pharmaceuticals, Inc. from 2010 to 2013, Secretary & General Counsel at Trius Therapeutics, Inc. in 2013, Secretary & General Counsel at Ignyta, Inc. from 2014 to 2016, and CFO, Secretary, CAO & General Counsel at Cidara Therapeutics, Inc. in 2018.
Education includes an undergraduate degree from Carnegie Mellon University in 1993 and a graduate degree from Stanford Law School in 1998.
Actieve functies van Matthew Onaitis
| Bedrijven | Functie | Begin |
|---|---|---|
| MAINSTAY MEDICAL INTERNATIONAL | Financieel Directeur/CFO | 20-08-2018 |
Snp Bio, Inc. | Directeur/Bestuurslid | - |
Stratify Genomics, Inc.
 Stratify Genomics, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer risk stratification company | Directeur/Bestuurslid | - |
Mainstay Medical Holdings Plc
 Mainstay Medical Holdings Plc Financial ConglomeratesFinance Functions as an investment holding company | Financieel Directeur/CFO | - |
Eerdere bekende functies van Matthew Onaitis
| Bedrijven | Functie | Einde |
|---|---|---|
| CIDARA THERAPEUTICS | Financieel Directeur/CFO | 17-08-2018 |
| IGNYTA INC | Algemeen Adviseur | 01-06-2016 |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Algemeen Adviseur | 01-12-2013 |
Somaxon Pharmaceuticals, Inc.
 Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Algemeen Adviseur | 01-03-2013 |
| BIOGEN INC. | Corporate Officer/Principal | 01-05-2006 |
Opleiding van Matthew Onaitis
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
77
Eerstegraads connecties
12
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Mainstay Medical International Ltd.
 Mainstay Medical International Ltd. Medical SpecialtiesHealth Technology Operates as a medical device company, which is engaged in the development of neurostimulation therapies for the population of people with debilitating chronic low back pain | Health Technology |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients | Health Technology |
Stanford Law School
 Stanford Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Snp Bio, Inc. | |
Stratify Genomics, Inc.
Stratify Genomics, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer risk stratification company | Health Services |
Mainstay Medical Holdings Plc
Mainstay Medical Holdings Plc Financial ConglomeratesFinance Functions as an investment holding company | Finance |
